OBJECTIVE

Recent public health recommendations emphasize adopting a healthful dietary pattern, but evidence is scarce on whether incremental diet quality changes have an impact on long-term diabetes prevention. We aim to evaluate diet quality changes during a 4-year period and subsequent 4-year type 2 diabetes incidence.

RESEARCH DESIGN AND METHODS

Participants of prospective cohorts, the Nurses’ Health Study (NHS), NHS II, and the Health Professionals Follow-up Study, who were free of diabetes at baseline (n = 124,607), were observed for ≥20 years. Diet quality, reflected by the Alternate Healthy Eating Index (AHEI) score, was assessed every 4 years to calculate changes.

RESULTS

We documented 9,361 cases of type 2 diabetes during 2,093,416 person-years of follow-up. A >10% decrease in AHEI score over 4 years was associated with a higher subsequent diabetes risk (pooled hazard ratio 1.34 [95% CI 1.23–1.46]) with multiple adjustment, whereas a >10% increase in AHEI score was associated with a lower risk (0.84 [0.78–0.90]). Greater improvement in diet quality was associated with lower diabetes risk across baseline diet quality status (P for trend ≤ 0.001 for low, medium, or high initial diet quality) and baseline BMI (P for trend ≤ 0.01 for BMI <25, 25–29, or 30 kg/m2). Changes in body weight explained 32% (95% CI 24–41) of the association between AHEI changes (per 10% increase) and diabetes risk.

CONCLUSIONS

Improvement in overall diet quality is associated with a lower risk of type 2 diabetes, whereas deterioration in diet quality is associated with a higher risk. The association between diet quality changes and diabetes risk is only partly explained by body weight changes.

Evidence from prospective observational studies and clinical trials has demonstrated the importance of diet in the prevention of type 2 diabetes (1). In randomized controlled trials (RCTs), lifestyle changes, including individually tailored, macronutrient composition, focused dietary interventions, prevented or delayed type 2 diabetes among individuals at high risk (2,3). However, long-term maintenance of calorie-restricted and macronutrient-focused diets has been challenging (4). Further, these tailored therapeutic approaches are difficult to communicate in general populations. Therefore, improving the overall quality of diet, which allows flexibility in food choices, may be more practical for maintaining long-term compliance and sustainability for diabetes prevention.

Healthful dietary patterns, which have emerged from various target populations, have been associated with type 2 diabetes prevention (58). These dietary patterns are typically rich in whole grains, fruits and vegetables, nuts, and legumes; are moderate in alcohol consumption; and are lower in refined grains, red/processed meats, and sugar-sweetened beverages (1). In an RCT among participants who are at risk for cardiovascular disease (CVD), those assigned to a consume a high-quality diet with extra-virgin olive oil supplementation had a significant diabetes risk reduction after 4.1 years of follow-up (9).

In recent years, public health recommendations have increasingly focused on advocating the improvement of overall diet quality to prevent chronic disease (1012), but scientific evidence is scarce on whether incremental improvement in the overall diet quality has a long-term preventive impact on type 2 diabetes in general populations. Healthful dietary patterns have been associated with type 2 diabetes prevention (1). However, the majority of these studies were conducted with a baseline measure of dietary variables only, and the impact of changes in dietary patterns has not been assessed in large population studies. Further, RCT evidence has shown that improvement in diet quality reduces type 2 diabetes risk (9,13), but it is unclear whether deterioration in diet quality can worsen the risk of the development of diabetes. Therefore, we investigated whether change in overall diet quality over a 4-year period was associated with type 2 diabetes risk in a subsequent 4-year follow-up in three large population-based cohorts of men and women with long-term follow-up and repeated measures of exposure (diet) and outcome (diabetes). To assess overall diet quality changes, we calculated changes in Alternate Healthy Eating Index (AHEI) scores every 4 years. This score was used to represent adherence to healthy eating for chronic disease prevention, as previously developed in the current study cohorts (8).

Study Population

The Nurses’ Health Study (NHS) is a prospective cohort study of 121,700 female registered nurses (age range 30–55 years) living across the U.S. at the baseline data collection in 1976. The NHS II is another prospective cohort of 116,671 younger female registered nurses from the U.S. (age range 25–42 years) at baseline in 1989. The Health Professionals Follow-up Study (HPFS) is a prospective cohort study of 51,529 male health professionals from the U.S. who were 40–75 years of age at study enrollment in 1986. Participants underwent follow-up biennially using validated questionnaires on medical history and lifestyle. The study protocol was approved by the Institutional Review Board of the Brigham and Women’s Hospital and the Human Subjects Committee Review Board of Harvard T.H. Chan School of Public Health.

The earliest year with detailed information available on diet and other lifestyle information, which was 1991 in the NHS II and 1986 in the NHS and HPFS, was used as the baseline in the current analysis. We excluded participants with a history of diabetes (i.e., type 1 diabetes, type 2 diabetes, and gestational diabetes mellitus) (n = 7,295 in NHS, n = 2,109 in NHS II, and n = 2,340 in HPFS), CVD (n = 7,097 in NHS, n = 1,745 in NHS II, and n = 6,509 in HPFS), or cancer (n = 9,810 in NHS, n = 2,714 in NHS II, and n = 1,493 in HPFS) at baseline, and incident cases during the first 4 years of follow-up (between 1986 and 1990 in the NHS and HPFS, and between 1991 and 1995 in the NHS II) because we were investigating 4-year changes in lifestyle exposures. We excluded deaths that occurred during that 4-year period (n = 2,302 in NHS, 193 in NHS II, and 686 in HPFS). The participants with missing food frequency questionnaires (FFQs) at the baseline of the current analysis follow-up period were excluded (n = 31,314 in NHS, n = 29,577 in NHS II, and n = 1,160 in HPFS). Participants who provided FFQ data had similar baseline characteristics such as age and BMI compared with those with missing FFQ data (Supplementary Table 1). Further, we excluded participants who left >10 items blank on the FFQ at baseline, who had a missing date of birth, who had missing BMI or physical activity variables at baseline, who were pregnant during the FFQ report cycle, or who reported unusual total energy intake on the baseline FFQ (i.e., <800 or >4,200 kcal/day for men and <500 or >3,500 kcal/day for women). A total of 48,612 women in the NHS, 49,711 women in the NHS II, and 26,284 men in the HPFS were included in the current analysis.

Dietary Assessment

Dietary intake was assessed using a semiquantitative FFQ at baseline and was updated every 4 years (1416). For each food item, participants were asked to report their usual intake of a standard portion of each food item from the previous year. The daily nutrient intake was estimated using the Harvard Food Composition Database derived from the U.S. Department of Agriculture nutrient data. The reproducibility and validity of nutrient, food, and dietary pattern measurements in the NHS and HPFS have been documented in detail (1417).

Changes in diet quality were assessed by calculating changes in the AHEI 2010 score. The AHEI 2010 was based on a comprehensive review of the relevant literature to identify foods and nutrients that have been consistently associated with a lower risk of chronic disease (8). It was updated from the original AHEI (18). The AHEI was designed to provide quantitative scoring for adherence to dietary guidance (18). The rationale for variable selection and scoring criteria of the AHEI 2010 was described in detail previously (8). The score consisted of 11 components, which included higher intakes of vegetables, fruits, whole grains, nuts and legumes, long-chain n-3 fatty acids, and polyunsaturated fatty acids (excluding long-chain n-3 fatty acids); lower intakes of red/processed meat, sugar-sweetened beverages and fruit juice, transfat, and sodium; and moderate alcohol consumption, as being adherence to healthy eating. Each component score ranged from 0 (least healthy eating behavior) to 10 (maximum adherence), and the total AHEI 2010 score ranged from 0 to 110 (maximum adherence).

Other Exposure Assessment

Information on physical activity, body weight, other lifestyle information, and medical history was collected at baseline, and was updated through biennial questionnaires. BMI was calculated as weight (in kilograms) self-reported divided by the square of height (in meters). Based on the previous validation study, self-reported weights were highly correlated with measured weights (r = 0.97) (19). Information on cigarette smoking, family history of diabetes, postmenopausal hormone use, and history of hypertension or hypercholesterolemia was assessed from these questionnaires by self-report. The validity of these assessments has been documented previously (20,21).

Ascertainment of Type 2 Diabetes

In the baseline questionnaire and all biennial follow-up questionnaires, participants were asked about the incidence of physician-diagnosed diabetes. Participants who reported such a diagnosis completed a supplementary questionnaire asking about symptoms, diagnostic tests, and treatment to confirm diagnosis. The validity of the supplementary questionnaire for type 2 diabetes, in which self-reported diagnosis of diabetes was confirmed by medical records reviewed by an endocrinologist who was blinded to the supplementary questionnaire information for 61 of 62 (98%) randomly selected NHS participants and 57 of 59 (97%) HPFS participants, has been documented previously (22,23).

The diagnosis was confirmed if at least one of the following was reported according to the National Diabetes Data Group criteria (24): 1) at least one symptom (excessive thirst, polyuria, weight loss, or hunger) plus fasting glucose concentration of ≥7.8 mmol/L or random glucose concentration of ≥11.1 mmol/L; 2) in the absence of symptoms, at least two elevated glucose concentrations on different occasions (fasting glucose concentration >7.8 mmol/L, random glucose concentration ≥11.1 mmol/L, and/or 2-h postload concentration ≥11.1 mmol/L at an oral glucose tolerance test); or 3) treatment with insulin or oral hypogycemic medication. For the cases after 1998, the revised American Diabetes Association criteria were applied using the fasting glucose concentration cutoff of 7.0 mmol/L (25).

Statistical Analyses

Participants contributed person-time from the return of the baseline questionnaire until the date of diagnosis of type 2 diabetes, death, or the end of the follow-up (2011 for the NHS II, and 2010 for the NHS and HPFS), whichever came first. We used multivariable time-dependent Cox proportional hazards models to estimate hazard ratio (HR) and 95% CI. The HRs were pooled from the multivariable adjusted models in each cohort to obtain summarized risk estimates. The time scale for the left truncated survival model was age, which was stratified by calendar time in 4-year groups, in addition to accounting for study cohorts in pooled analyses. We quantified a linear trend across AHEI change categories with a Wald test for linear trend by assigning the median value to each category and modeling this variable as a continuous variable. We assessed a potential nonlinear relation between the changes in the AHEI and incident type 2 diabetes by using restricted cubic spline transformations without prior specification of the risk function (26). We performed tests for nonlinearity by using the likelihood ratio test and compared the model with the linear term only with the model with both the linear and cubic spline terms.

To assess the associations between changes in diet quality and subsequent risk for type 2 diabetes, we used changes in AHEI scores updated every 4 years as a time-varying exposure for type 2 diabetes risk in the subsequent 4 years. In addition to accounting for age, regression models were adjusted for potential confounding factors including ethnicity (white/nonwhite); family history of diabetes (yes/no); baseline AHEI, physical activity, and total energy intake at the beginning of each 4-year period (all in quintiles); 4-year changes in smoking status (never to never, never to current, past to past, past to current, current to past, current to current, or missing indicator), physical activity, and total energy intake (all in quintiles); and a medical history of hypertension (yes/no) and hypercholesterolemia (yes/no) (model 1). In the NHS and NHS II, postmenopausal status and postmenopausal hormone use (never use, current use, past use, or missing) were also included. We additionally adjusted for baseline BMI at the beginning of each 4-year period (<21, 21–22.9, 23–24.9, 25–29.9, and ≥30 kg/m2) in a separate model (model 2) because the association under investigation might be mediated by body weight. Since changes in body weight may be a mediator of the association between changes in AHEI and risk of type 2 diabetes, we further adjusted model 2 with 4-year changes in body weight. To evaluate the contribution of body weight changes over the same period on the association between changes in AHEI and the risk of type 2 diabetes, SAS macro %MEDIATE (publicly available at https://www.hsph.harvard.edu/donna-spiegelman/software/mediate/) was applied using 1-(βmediator model / βbase model) × 100 according to the methods described by Lin et al. (27). Trends of increases and decreases in AHEI scores were evaluated by modeling score changes in categories with “no change or less than ±3%” as a reference.

We tested multiplicative interactions of changes in AHEI scores with age, hypertension, hypercholesterolemia, current smoking status, and BMI at the beginning of the 4-year period, using likelihood ratio tests. To consider the ceiling effect of the baseline diet quality, we stratified the analysis by the baseline AHEI scores (<45, 45–49, and ≥50). To assess the stability of the associations across simultaneously changing categories of physical activity, we assessed the associations stratified by changes in physical activity levels (decreased, stable as ±2 MET-h/week change, and increased). Further, we performed a sensitivity analysis of calculating the AHEI score without the long-chain n-3 fatty acid component because of the small positive association between long-chain n-3 fatty acid intake and type 2 diabetes observed previously in the current study cohorts (28). AHEI score, physical activity, and weight change variables were assessed with the use of censoring of data at the 0.5 and 99.5 percentiles to minimize the influence of outliers. To minimize missing values during follow-up, missing variables were replaced with carried forward values for continuous variables, and a missing indicator was added for categorical variables. For all statistical analyses, a two-sided P value of <0.05 was considered to be statistically significant. All data analyses were performed using SAS software, version 9.3 for UNIX (SAS Institute, Cary, NC).

We documented 9,361 incident type 2 diabetes cases (4,308 in the NHS, 3,136 in the NHS II, and 1,917 in the HPFS) during 2,093,416 person-years of follow-up. Baseline characteristics of study participants are presented across the 4-year changes in the percentage AHEI scores among U.S. women and men in three prospective cohorts (Table 1). Participants who had improved the diet quality generally had a lower AHEI score and physical activity levels at baseline compared with those who had a worsened diet quality.

Table 1

Baseline characteristics according to 4-year changes in percent diet quality scores among U.S. women and men in three prospective cohorts

Change in diet quality (categories in % score change)
Decrease
No change or stable (±<3%)Increase
Moderate to large (>10%)Small to moderate (3–10%)Small to moderate (3–10%)Moderate to large (>10%)
NHS (1990)      
 Participants, n 3,719 10,900 15,199 13,050 5,744 
 Age, years 56.2 ± 7.2 55.9 ± 7.1 55.9 ± 7.1 55.8 ± 7.0 56.0 ± 7.0 
 BMI, kg/m2 24.9 ± 4.5 24.9 ± 4.4 24.9 ± 4.5 25.0 ± 4.5 25.1 ± 4.8 
 AHEI score 62.1 ± 10.6 55.6 ± 10.5 51.5 ± 10.4 48.2 ± 10.0 44.4 ± 9.5 
 Physical activity, MET-h/week 16.0 ± 21.3 14.4 ± 20.9 14.4 ± 21.6 13.8 ± 19.4 13.8 ± 20.1 
 White ethnicity, % 98.5 98.7 98.3 98.0 97.3 
 Current smoker, % 15.8 16.6 15.8 16.1 15.9 
 Hypertension, % 23.2 22.2 22.0 22.0 23.5 
 High cholesterol, % 30.9 32.3 33.4 35.4 38.4 
 Family history of diabetes, % 28.6 28.2 28.4 28.5 27.9 
 Total energy intake, kcal/day 1,794 ± 542 1,800 ± 527 1,786 ± 519 1,739 ± 503 1,717 ± 486 
 Menopausal status and postmenopausal hormone use, %      
  Premenopausal 29.2 31.2 31.1 31.2 29.7 
  Postmenopausal + never users 27.2 27.4 27.0 27.1 28.2 
  Postmenopausal + current users 26.4 26.0 25.8 26.0 26.2 
  Postmenopausal + past users 15.0 13.4 14.2 13.6 14.1 
  Missing information 2.3 2.0 2.0 2.2 1.8 
NHS II (1995)      
 Participants, n 4,379 11,245 15,266 13,110 5,711 
 Age, years 41.7 ± 4.0 41.9 ± 4.0 41.9 ± 4.0 41.9 ± 4.1 41.9 ± 4.2 
 BMI, kg/m2 25.4 ± 5.6 24.8 ± 5.3 24.6 ± 5.2 24.6 ± 5.4 24.7 ± 5.5 
 AHEI score 59.5 ± 9.7 52.8 ± 9.9 48.4 ± 10.1 45.4 ± 10.0 42.2 ± 9.5 
 Physical activity, MET-h/week 24.0 ± 32.5 21.1 ± 27.7 19.6 ± 25.0 19.7 ± 26.2 19.2 ± 24.5 
 White ethnicity, % 97.1 96.7 97.0 97.0 96.6 
 Current smoker, % 12.3 11.4 11.3 11.5 11.9 
 Hypertension, % 13.4 10.6 10.4 10.0 10.7 
 High cholesterol, % 24.8 22.6 22.6 22.9 22.7 
 Family history of diabetes, % 37.1 36.8 36.5 35.5 36.8 
 Total energy intake, kcal/day 1,669 ± 519 1,708 ± 527 1,755 ± 531 1,780 ± 521 1,829 ± 516 
 Menopausal status and postmenopausal hormone use, %      
  Premenopausal 86.9 88.2 88.1 87.8 86.6 
  Postmenopausal + never users 0.6 0.6 0.7 0.7 0.7 
  Postmenopausal + past users 1.1 1.0 0.9 1.1 1.1 
  Postmenopausal + current users 8.8 7.6 7.8 7.7 8.7 
  Missing information 2.7 2.6 2.5 2.8 3.1 
 Oral contraceptive use, %      
  Never user 14.8 14.1 14.6 14.5 14.3 
  Past user 78.1 79.4 79.0 78.0 78.3 
  Current user 7.1 6.5 6.4 7.4 7.4 
Health Professionals Follow-up Study (1990)      
 Participants, n 2,216 5,998 8,155 6,755 3,160 
 Age, years 56.0 ± 9.2 56.0 ± 9.2 56.1 ± 9.1 56.1 ± 9.0 56.8 ± 9.1 
 BMI, kg/m2 25.3 ± 3.3 25.3 ± 3.0 25.3 ± 3.0 25.2 ± 2.9 25.3 ± 3.0 
 AHEI score 61.6 ± 10.9 55.9 ± 11.0 52.1 ± 10.8 49.1 ± 10.6 46.3 ± 10.2 
 Physical activity, MET-h/week 23.7 ± 38.8 22.4 ± 30.0 21.3 ± 28.0 21.4 ± 30.6 21.1 ± 28.9 
 White ethnicity, % 95.9 96.4 95.9 95.9 94.7 
 Current smoker, % 8.9 7.8 7.9 7.1 6.8 
 Hypertension, % 16.1 14.7 15.5 15.2 15.7 
 High cholesterol, % 15.7 17.2 18.9 21.6 27.6 
 Family history of diabetes, % 20.9 20.0 20.9 21.4 19.7 
 Total energy intake, kcal/day 2,011 ± 603 2,032 ± 608 2,030 ± 603 1,996 ± 585 1,943 ± 569 
Change in diet quality (categories in % score change)
Decrease
No change or stable (±<3%)Increase
Moderate to large (>10%)Small to moderate (3–10%)Small to moderate (3–10%)Moderate to large (>10%)
NHS (1990)      
 Participants, n 3,719 10,900 15,199 13,050 5,744 
 Age, years 56.2 ± 7.2 55.9 ± 7.1 55.9 ± 7.1 55.8 ± 7.0 56.0 ± 7.0 
 BMI, kg/m2 24.9 ± 4.5 24.9 ± 4.4 24.9 ± 4.5 25.0 ± 4.5 25.1 ± 4.8 
 AHEI score 62.1 ± 10.6 55.6 ± 10.5 51.5 ± 10.4 48.2 ± 10.0 44.4 ± 9.5 
 Physical activity, MET-h/week 16.0 ± 21.3 14.4 ± 20.9 14.4 ± 21.6 13.8 ± 19.4 13.8 ± 20.1 
 White ethnicity, % 98.5 98.7 98.3 98.0 97.3 
 Current smoker, % 15.8 16.6 15.8 16.1 15.9 
 Hypertension, % 23.2 22.2 22.0 22.0 23.5 
 High cholesterol, % 30.9 32.3 33.4 35.4 38.4 
 Family history of diabetes, % 28.6 28.2 28.4 28.5 27.9 
 Total energy intake, kcal/day 1,794 ± 542 1,800 ± 527 1,786 ± 519 1,739 ± 503 1,717 ± 486 
 Menopausal status and postmenopausal hormone use, %      
  Premenopausal 29.2 31.2 31.1 31.2 29.7 
  Postmenopausal + never users 27.2 27.4 27.0 27.1 28.2 
  Postmenopausal + current users 26.4 26.0 25.8 26.0 26.2 
  Postmenopausal + past users 15.0 13.4 14.2 13.6 14.1 
  Missing information 2.3 2.0 2.0 2.2 1.8 
NHS II (1995)      
 Participants, n 4,379 11,245 15,266 13,110 5,711 
 Age, years 41.7 ± 4.0 41.9 ± 4.0 41.9 ± 4.0 41.9 ± 4.1 41.9 ± 4.2 
 BMI, kg/m2 25.4 ± 5.6 24.8 ± 5.3 24.6 ± 5.2 24.6 ± 5.4 24.7 ± 5.5 
 AHEI score 59.5 ± 9.7 52.8 ± 9.9 48.4 ± 10.1 45.4 ± 10.0 42.2 ± 9.5 
 Physical activity, MET-h/week 24.0 ± 32.5 21.1 ± 27.7 19.6 ± 25.0 19.7 ± 26.2 19.2 ± 24.5 
 White ethnicity, % 97.1 96.7 97.0 97.0 96.6 
 Current smoker, % 12.3 11.4 11.3 11.5 11.9 
 Hypertension, % 13.4 10.6 10.4 10.0 10.7 
 High cholesterol, % 24.8 22.6 22.6 22.9 22.7 
 Family history of diabetes, % 37.1 36.8 36.5 35.5 36.8 
 Total energy intake, kcal/day 1,669 ± 519 1,708 ± 527 1,755 ± 531 1,780 ± 521 1,829 ± 516 
 Menopausal status and postmenopausal hormone use, %      
  Premenopausal 86.9 88.2 88.1 87.8 86.6 
  Postmenopausal + never users 0.6 0.6 0.7 0.7 0.7 
  Postmenopausal + past users 1.1 1.0 0.9 1.1 1.1 
  Postmenopausal + current users 8.8 7.6 7.8 7.7 8.7 
  Missing information 2.7 2.6 2.5 2.8 3.1 
 Oral contraceptive use, %      
  Never user 14.8 14.1 14.6 14.5 14.3 
  Past user 78.1 79.4 79.0 78.0 78.3 
  Current user 7.1 6.5 6.4 7.4 7.4 
Health Professionals Follow-up Study (1990)      
 Participants, n 2,216 5,998 8,155 6,755 3,160 
 Age, years 56.0 ± 9.2 56.0 ± 9.2 56.1 ± 9.1 56.1 ± 9.0 56.8 ± 9.1 
 BMI, kg/m2 25.3 ± 3.3 25.3 ± 3.0 25.3 ± 3.0 25.2 ± 2.9 25.3 ± 3.0 
 AHEI score 61.6 ± 10.9 55.9 ± 11.0 52.1 ± 10.8 49.1 ± 10.6 46.3 ± 10.2 
 Physical activity, MET-h/week 23.7 ± 38.8 22.4 ± 30.0 21.3 ± 28.0 21.4 ± 30.6 21.1 ± 28.9 
 White ethnicity, % 95.9 96.4 95.9 95.9 94.7 
 Current smoker, % 8.9 7.8 7.9 7.1 6.8 
 Hypertension, % 16.1 14.7 15.5 15.2 15.7 
 High cholesterol, % 15.7 17.2 18.9 21.6 27.6 
 Family history of diabetes, % 20.9 20.0 20.9 21.4 19.7 
 Total energy intake, kcal/day 2,011 ± 603 2,032 ± 608 2,030 ± 603 1,996 ± 585 1,943 ± 569 

Values are reported as the mean ± SD, unless otherwise indicated.

Table 2 shows HRs of type 2 diabetes according to the 4-year changes in diet quality. A >10% decrease in AHEI scores over 4 years was associated with a higher subsequent risk of diabetes (pooled HR 1.34 [95% CI 1.23–1.46]) compared with participants who maintained relatively stable diet quality in each 4-year period with multiple adjustments in model 1, whereas an improvement of >10% in AHEI score was associated with a lower risk of diabetes (0.84 [0.78–0.90]). The association was attenuated slightly but remained significant with additional adjustment for baseline BMI at the beginning of each 4-year period in model 2 (pooled P value for trend <0.0001) (Table 2). The significance of the association remained when model 2 was further adjusted for changes in body weight over the same period: >10% decrease in AHEI scores over 4 years was associated with a higher subsequent diabetes risk (1.21 [1.11–1.32]), whereas an improvement of >10% in AHEI scores was associated with a lower risk (0.90 [0.84–0.96]). When the AHEI score was assessed as a continuous variable, each 10% incremental improvement in the score was associated with a 0.85 (0.83–0.88) risk of the development of type 2 diabetes over the subsequent 4-year period (0.89 [0.86–0.91]) in model 2, and a 0.91 (0.88–0.93) risk with additional adjustment for changes in body weight. Changes in body weight explained 32% (95% CI 24–41) of the association between changes in AHEI (per 10% increase) and the risk of type 2 diabetes with adjustment for model 2 variables (P value for contribution < 0.0001).

Table 2

HRs of type 2 diabetes according to updated 4-year changes in dietary quality (categories in AHEI scores)

Decrease
No change or stable(±<3%)Increase
P for trendHR per 10% score increase
Moderate to large (>10%)Small to moderate(3–10%)Small to moderate(3–10%)Moderate to large (>10%)
NHS (1986–2010)        
 Cases/person-years 358/61,075 870/176,310 1,477/300,169 1,074/226,534 529/109,284   
 Model 1* 1.33 (1.18–1.50) 1.06 (0.97–1.15) 1.00 0.93 (0.85–1.00) 0.87 (0.78–0.96) <0.0001 0.86 (0.83–0.90) 
 Model 2 1.27 (1.13–1.43) 1.04 (0.95–1.13) 1.00 0.95 (0.88–1.03) 0.89 (0.80–0.99) <0.0001 0.89 (0.85–0.93) 
NHS II (1991–2011)        
 Cases/person-years 258/47,760 539/127,070 1,143/265,994 705/189,609 491/129,739   
 Model 1* 1.45 (1.25–1.67) 1.09 (0.97–1.21) 1.00 0.85 (0.77–0.94) 0.76 (0.67–0.85) <0.0001 0.81 (0.78–0.85) 
 Model 2 1.31 (1.13–1.51) 1.03 (0.93–1.15) 1.00 0.88 (0.80–0.98) 0.77 (0.69–0.87) <0.0001 0.85 (0.81–0.89) 
HPFS (1986–2010)        
 Cases/person-years 118/27,668 340/83,582 734/176,678 470/116,985 255/54,959   
 Model 1* 1.15 (0.93–1.41) 1.02 (0.89–1.17) 1.00 0.92 (0.81–1.04) 0.99 (0.85–1.16) 0.14 0.94 (0.87–1.00) 
 Model 2 1.05 (0.86–1.30) 0.98 (0.86–1.13) 1.00 0.94 (0.83–1.07) 1.01 (0.86–1.18) 0.67 0.97 (0.91–1.04) 
Pooled        
 Model 1* 1.34 (1.23–1.46) 1.06 (1.00–1.13) 1.00 0.90 (0.85–0.94) 0.84 (0.78–0.90) <0.0001 0.85 (0.83–0.88) 
 Model 2 1.25 (1.15–1.36) 1.03 (0.97–1.09) 1.00 0.93 (0.88–0.98) 0.86 (0.81–0.93) <0.0001 0.89 (0.86–0.91) 
Decrease
No change or stable(±<3%)Increase
P for trendHR per 10% score increase
Moderate to large (>10%)Small to moderate(3–10%)Small to moderate(3–10%)Moderate to large (>10%)
NHS (1986–2010)        
 Cases/person-years 358/61,075 870/176,310 1,477/300,169 1,074/226,534 529/109,284   
 Model 1* 1.33 (1.18–1.50) 1.06 (0.97–1.15) 1.00 0.93 (0.85–1.00) 0.87 (0.78–0.96) <0.0001 0.86 (0.83–0.90) 
 Model 2 1.27 (1.13–1.43) 1.04 (0.95–1.13) 1.00 0.95 (0.88–1.03) 0.89 (0.80–0.99) <0.0001 0.89 (0.85–0.93) 
NHS II (1991–2011)        
 Cases/person-years 258/47,760 539/127,070 1,143/265,994 705/189,609 491/129,739   
 Model 1* 1.45 (1.25–1.67) 1.09 (0.97–1.21) 1.00 0.85 (0.77–0.94) 0.76 (0.67–0.85) <0.0001 0.81 (0.78–0.85) 
 Model 2 1.31 (1.13–1.51) 1.03 (0.93–1.15) 1.00 0.88 (0.80–0.98) 0.77 (0.69–0.87) <0.0001 0.85 (0.81–0.89) 
HPFS (1986–2010)        
 Cases/person-years 118/27,668 340/83,582 734/176,678 470/116,985 255/54,959   
 Model 1* 1.15 (0.93–1.41) 1.02 (0.89–1.17) 1.00 0.92 (0.81–1.04) 0.99 (0.85–1.16) 0.14 0.94 (0.87–1.00) 
 Model 2 1.05 (0.86–1.30) 0.98 (0.86–1.13) 1.00 0.94 (0.83–1.07) 1.01 (0.86–1.18) 0.67 0.97 (0.91–1.04) 
Pooled        
 Model 1* 1.34 (1.23–1.46) 1.06 (1.00–1.13) 1.00 0.90 (0.85–0.94) 0.84 (0.78–0.90) <0.0001 0.85 (0.83–0.88) 
 Model 2 1.25 (1.15–1.36) 1.03 (0.97–1.09) 1.00 0.93 (0.88–0.98) 0.86 (0.81–0.93) <0.0001 0.89 (0.86–0.91) 

Values are reported as HR (95% CI), unless otherwise indicated.

*Model 1 was adjusted for age; ethnicity (white/nonwhite); family history of diabetes (yes/no); baseline AHEI score, physical activity, and total energy intake at the beginning of each 4-year period (all in quintiles); 4-year changes in smoking status (never to never, never to current, past to past, past to current, current to past, current to current, or missing indicator), physical activity, and total energy intake (all in quintiles); and a medical history of hypertension (yes/no) and hypercholesterolemia (yes/no). In the NHS and NHS II, postmenopausal status and postmenopausal hormone use (never use, current use, past use, or missing) were also included.

†Model 2 was adjusted for model 1 variables in addition to baseline BMI values at the beginning of each 4-year period (<21, 21–22.9, 23–24.9, 25–29.9, ≥30 kg/m2).

To assess the impact of baseline diet quality on the association between changes in diet quality and type 2 diabetes risk, the association was stratified by baseline diet quality in Table 3 (P value for interaction = 0.2). The significant association remained across low, medium, and high baseline diet quality (all P for trend ≤ 0.001) (Table 3). Similarly in Table 4, the association was stratified by baseline BMI (P for interaction = 0.001). The association between changes in diet quality and type 2 diabetes risk remained significant across categories of baseline BMI (P for trend ≤ 0.01 for BMI values of <25, 25–29, and 30 kg/m2) (Table 4). No significant effect modification was observed for the association between changes in AHEI score and incidence of type 2 diabetes by comorbidity of hypertension, hypercholesterolemia, or current smoking status. When the association was stratified by age-groups (P for interaction = 0.02), the inverse associations were more pronounced in younger than in older participants: HR 0.83 (95% CI 0.78–0.89) in participants <50 years of age, 0.89 (0.85–0.92) in participants 50–64 years of age, and 0.93 (0.89–0.98) in participants ≥65 years of age per 10% AHEI score increase (Supplementary Table 2).

Table 3

HRs of type 2 diabetes according to 4-year changes in dietary quality (categories in AHEI scores) stratified by categories of AHEI scores at the beginning of the 4-year period, pooled results of NHS (1986–2010), NHS II (1991–2011), and HPFS (1986–2010)*

Initial diet quality scoresDiet quality change category 4 years later
P for trendHR per 10% score increase
Decrease
No change or stable (±<3%)Increase
Moderate to large (>10%)Small to moderate (3–10%)Small to moderate(3–10%)Moderate to large (>10%)
Low (<45) 1.56 (1.18–2.06) 1.05 (0.92–1.20) 1.00 0.95 (0.86–1.04) 0.83 (0.75–0.93) <0.0001 0.88 (0.84–0.93) 
Medium (45–59) 1.13 (1.00–1.27) 0.99 (0.91–1.07) 1.00 0.93 (0.85–1.00) 0.90 (0.82–1.00) 0.001 0.93 (0.89–0.96) 
High (≥60) 1.31 (1.14–1.50) 1.07 (0.94–1.21) 1.00 0.88 (0.76–1.02) 0.96 (0.78–1.18) <0.0001 0.87 (0.82–0.92) 
Initial diet quality scoresDiet quality change category 4 years later
P for trendHR per 10% score increase
Decrease
No change or stable (±<3%)Increase
Moderate to large (>10%)Small to moderate (3–10%)Small to moderate(3–10%)Moderate to large (>10%)
Low (<45) 1.56 (1.18–2.06) 1.05 (0.92–1.20) 1.00 0.95 (0.86–1.04) 0.83 (0.75–0.93) <0.0001 0.88 (0.84–0.93) 
Medium (45–59) 1.13 (1.00–1.27) 0.99 (0.91–1.07) 1.00 0.93 (0.85–1.00) 0.90 (0.82–1.00) 0.001 0.93 (0.89–0.96) 
High (≥60) 1.31 (1.14–1.50) 1.07 (0.94–1.21) 1.00 0.88 (0.76–1.02) 0.96 (0.78–1.18) <0.0001 0.87 (0.82–0.92) 

Values are reported as HR (95% CI), unless otherwise indicated.

*Adjusted for age; ethnicity (white/nonwhite); family history of diabetes (yes/no); baseline physical activity and total energy intake at the beginning of each 4-year period (all in quintiles); 4-year changes in smoking status (never to never, never to current, past to past, past to current, current to past, current to current, or missing indicator), physical activity, and total energy intake (all in quintiles); a medical history of hypertension (yes/no) and hypercholesterolemia (yes/no); and baseline BMI values at the beginning of each 4-year period. In the NHS and NHS II, postmenopausal status and postmenopausal hormone use (never use, current use, past use, or missing) were also included.

Table 4

HRs of type 2 diabetes according to 4-year changes in dietary quality (categories in AHEI scores) stratified by BMI at the beginning of the 4-year period, pooled results of NHS (1986–2010), NHS II (1991–2011), and HPFS (1986–2010)*

Initial BMI (kg/m2)Diet quality change category 4 years later
P for trendHR per 10% score increase
Decrease
No change or stable (±<3%)Increase
Moderate to large(>10%)Small to moderate(3–10%)Small to moderate(3–10%)Moderate to large(>10%)
<25 1.12 (0.89–1.42) 1.01 (0.85–1.18) 0.91 (0.78–1.06) 0.84 (0.69–1.01) 0.01 0.89 (0.82–0.96) 
25–29 1.37 (1.20–1.58) 0.99 (0.90–1.10) 0.98 (0.89–1.07) 0.94 (0.84–1.05) 0.0006 0.90 (0.86–0.94) 
≥30 1.21 (1.07–1.37) 1.06 (0.97–1.16) 0.89 (0.82–0.97) 0.82 (0.75–0.90) <0.0001 0.88 (0.84–0.91) 
Initial BMI (kg/m2)Diet quality change category 4 years later
P for trendHR per 10% score increase
Decrease
No change or stable (±<3%)Increase
Moderate to large(>10%)Small to moderate(3–10%)Small to moderate(3–10%)Moderate to large(>10%)
<25 1.12 (0.89–1.42) 1.01 (0.85–1.18) 0.91 (0.78–1.06) 0.84 (0.69–1.01) 0.01 0.89 (0.82–0.96) 
25–29 1.37 (1.20–1.58) 0.99 (0.90–1.10) 0.98 (0.89–1.07) 0.94 (0.84–1.05) 0.0006 0.90 (0.86–0.94) 
≥30 1.21 (1.07–1.37) 1.06 (0.97–1.16) 0.89 (0.82–0.97) 0.82 (0.75–0.90) <0.0001 0.88 (0.84–0.91) 

Values are reported as HR (95% CI), unless otherwise indicated.

*Adjusted for age; ethnicity (white/nonwhite); family history of diabetes (yes/no); baseline AHEI, physical activity, and total energy intake at the beginning of each 4-year period (all in quintiles); 4-year changes in smoking status (never to never, never to current, past to past, past to current, current to past, current to current, or missing indicator), physical activity, and total energy intake (all in quintiles); and a medical history of hypertension (yes/no) and hypercholesterolemia (yes/no). In the NHS and NHS II, postmenopausal status and postmenopausal hormone use (never use, current use, past use, or missing) were also included.

To test the stability of the associations simultaneously across the categories of changes in physical activity, the association between changes in diet quality and type 2 diabetes risk was assessed according to changes in physical activity (P for interaction = 0.8). The association remained significant across physical activity change categories (P for trend ≤ 0.0005 for participants whose physical activity decreased, remained stable, or increased) (Supplementary Table 3). The significance and direction of association remained when AHEI scores were calculated without the long-chain n-3 fatty acid component (Supplementary Table 4).

In three large prospective cohorts of U.S. men and women, improvement in overall diet quality over a 4-year period was associated with a lower risk of the development of type 2 diabetes in the subsequent 4 years, whereas deterioration in diet quality was associated with a higher risk. This association was only partly explained by concurrent changes in body weight, and remained across the categories of baseline diet quality and baseline BMI.

Previously, several healthful dietary patterns, developed in various study populations, have been associated with the risk of type 2 diabetes (1). Prospective data using exploratory methods to define patterns that supported dietary patterns favoring fruits, vegetables, and whole grains are beneficial for diabetes prevention, whereas patterns high in red meats, refined grains, and sugar-sweetened beverages are harmful (2934). Mediterranean-style diets have been consistently associated with lower incident type 2 diabetes in the context of both prospective cohort studies (5,6) and RCTs (9,13). Adherence to the Dietary Approaches to Stop Hypertension diet, which is rich in vegetables, fruits, and low-fat dairy products, was also associated with a lower diabetes risk (7,35). In the current study cohorts, adherence to a high-quality diet assessed by the cumulative AHEI scores was associated with a lower diabetes risk (8). The current study extends previous evidence by demonstrating that changing overall diet quality, assessed by changes in AHEI scores, has an impact on diabetes prevention in the subsequent years. In the randomized controlled PREDIMED (Prevención con Dieta Mediterránea) trial, participants assigned to a Mediterranean diet without calorie restriction had a significant 40% diabetes risk reduction with extra-virgin olive oil supplementation and a nonsignificant 18% risk reduction with mixed nut supplementation compared with a low-fat control diet after 4.1 years of follow-up (9). Here we reported that incremental changes in diet quality (per 10% improvement in AHEI score) were associated with an 11% reduction in diabetes risk. The effect sizes were smaller in the current study, likely because the PREDIMED trial selected participants who were at risk for CVD (9), whereas the current investigation represented a general population. The current study provides evidence for the incremental benefits of improving diet quality by following public health recommendations in a general population. In addition, we provide evidence, for the first time to our knowledge, that deterioration in diet quality is associated with a higher risk of the development of diabetes, independent of baseline BMI and concurrent changes in physical activity.

The potential mechanisms explaining the lower risk with improvement in overall diet quality are multifactorial because healthful dietary patterns include multiple food components. Changes in the consumption of individual food items that are known to be associated with type 2 diabetes risk have been also associated with long-term weight gain (36). Increased adipose mass may influence the pathogenesis of type 2 diabetes through mechanisms such as alterations in proinflammatory and anti-inflammatory proteins contributing to reduced sensitivity to insulin (37). However, concurrent changes in body weight only partly explained the association between changes in diet quality and diabetes risk in the current study. In addition, we tested using stratified analysis whether the benefits of diet quality changes remained throughout the categories of initial body weight and confirmed that the associations remained. This may be explained by multiple food components in overall diet contributing to multiple pathways to diabetes prevention. For example, moderate alcohol consumption has been associated with improved insulin sensitivity (38), whereas red/process meat intakes have been associated with weight gain (36). Previously in the current study cohorts, changes in the consumption of individual food items, such as of red meat (39) and alcohol (40), were associated with subsequent risk of the development of type 2 diabetes. Therefore, investigating the overall dietary quality accounting for food and nutrient interactions is helpful in understanding the overall role of dietary changes. In addition, communicating overall diet quality improvement offers a clearer message to the public as food items are consumed in combinations in the daily diet.

The strengths of the current study design, which include a large sample size with high long-term follow-up rates and repeated assessments of dietary and lifestyle variables, provided the unique ability to investigate changes in diet quality on the subsequent risk of type 2 diabetes. The current study also has several limitations. Our study participants were health professionals of primarily European ancestry, and, therefore, the observed associations may not be generalizable to other populations. Although AHEI score is useful to measure overall diet quality changes in the current study populations, it will be important to confirm our findings in other populations accounting for culturally suitable dietary patterns and potential confounding factors and practices specific to the population. Because of a ceiling effect among participants who start with a high AHEI score, the current results may underestimate the role of a healthful diet. However, in our stratified analysis by baseline diet quality, the reported association remained across the categories of baseline AHEI score. The observed beneficial effect of diet quality changes may have been confounded by other healthful behaviors, although we attempted to account for these confounders through statistical adjustment of regression models. The stratified analysis by changes in physical activity with adjustment for baseline BMI at the beginning of each 4-year period further demonstrates the beneficial effects of diet quality improvement both in groups that had improved and worsened physical activity levels. This confounding seemed to have a greater influence on older participants, especially among older men, since we observed that the associations were more pronounced in younger women. However, the current study was limited by its study design to understand the underlying behavioral and biological mechanisms. Investigations using longer-term trials controlled for potential confounders including caloric intakes, physical activity, and clinically measured covariates, such as blood pressure, will be needed to further understand the causality of the presently reported associations.

In conclusion, improving the overall diet quality over a 4-year period was associated with a lower risk of the development of type 2 diabetes in the subsequent 4 years in these prospective cohorts of U.S. adults, whereas deterioration in diet quality was associated with a higher risk of the development of type 2 diabetes, and the association between changes in diet quality and diabetes risk was only partly explained by changes in body weight. Expanding from previous RCT evidence that demonstrated that individually tailored dietary interventions can prevent or delay type 2 diabetes among those at high risk (1), we provide evidence that changing overall diet quality may have a significant impact on long-term diabetes risk. Further, our findings provide scientific evidence supporting the current public health recommendation (1012), which is to adopt healthful dietary patterns for long-term type 2 diabetes prevention.

Funding. This study was supported by National Institutes of Health research grants UM1-CA-186107, UM1-CA-176726, UM1-CA-167552, P01-CA-87969, DK-58845, HL-60712, and P30-DK-46200.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. S.H.L. and F.B.H. participated in the study concept and design and statistical analysis and interpretation. S.H.L. drafted the article. All authors participated in critical revision and approved the final version of the manuscript. S.H.L. and F.B.H. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Prior Presentation. Parts of this study were presented in abstract form at the 74th Scientific Sessions of the American Diabetes Association, San Francisco, CA, 13–17 June 2014.

1.
Ley
SH
,
Hamdy
O
,
Mohan
V
,
Hu
FB
.
Prevention and management of type 2 diabetes: dietary components and nutritional strategies
.
Lancet
2014
;
383
:
1999
2007
[PubMed]
2.
Tuomilehto
J
,
Lindström
J
,
Eriksson
JG
, et al.;
Finnish Diabetes Prevention Study Group
.
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
.
N Engl J Med
2001
;
344
:
1343
1350
[PubMed]
3.
Knowler
WC
,
Barrett-Connor
E
,
Fowler
SE
, et al.;
Diabetes Prevention Program Research Group
.
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
.
N Engl J Med
2002
;
346
:
393
403
[PubMed]
4.
Martínez-González
MA
,
Salas-Salvadó
J
,
Estruch
R
.
Intensive lifestyle intervention in type 2 diabetes
.
N Engl J Med
2013
;
369
:
2357
[PubMed]
5.
Romaguera
D
,
Guevara
M
,
Norat
T
, et al.;
InterAct Consortium
.
Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project
.
Diabetes Care
2011
;
34
:
1913
1918
[PubMed]
6.
Esposito
K
,
Maiorino
MI
,
Ceriello
A
,
Giugliano
D
.
Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review
.
Diabetes Res Clin Pract
2010
;
89
:
97
102
[PubMed]
7.
Liese
AD
,
Nichols
M
,
Sun
X
,
D’Agostino
RB
 Jr
,
Haffner
SM
.
Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the insulin resistance atherosclerosis study
.
Diabetes Care
2009
;
32
:
1434
1436
[PubMed]
8.
Chiuve
SE
,
Fung
TT
,
Rimm
EB
, et al
.
Alternative dietary indices both strongly predict risk of chronic disease
.
J Nutr
2012
;
142
:
1009
1018
[PubMed]
9.
Salas-Salvadó
J
,
Bulló
M
,
Estruch
R
, et al
.
Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial
.
Ann Intern Med
2014
;
160
:
1
10
[PubMed]
10.
U.S. Department of Agriculture (USDA). Scientific Report of the 2015 Dietary Guidelines Advisory Committee: Advisory Report to the Secretary of Health and Human Services and the Secretary of Agriculture, [article online] 2015. Available from https://health.gov/dietaryguidelines/2015-scientific-report/pdfs/scientific-report-of-the-2015-dietary-guidelines-advisory-committee.pdf. Accessed 20 February 2016
11.
U.S. Department of Health and Human Services
.
Dietary Guidelines for Americans 2015–2020
. 8th ed.
2015
12.
Health Canada
.
Eating Well with Canada’s Food Guide
.
Ottawa, ON
,
Health Canada
,
2011
13.
Salas-Salvadó
J
,
Bulló
M
,
Babio
N
, et al.;
PREDIMED Study Investigators
.
Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial
.
Diabetes Care
2011
;
34
:
14
19
[PubMed]
14.
Willett
WC
,
Sampson
L
,
Stampfer
MJ
, et al
.
Reproducibility and validity of a semiquantitative food frequency questionnaire
.
Am J Epidemiol
1985
;
122
:
51
65
[PubMed]
15.
Willett
W
.
Reproducibility and validity of food-frequency questionnaires
. In
Nutritional Epidemiology
. 2nd ed.
New York
,
Oxford University Press
,
1998
, p.
101
147
16.
Rimm
EB
,
Giovannucci
EL
,
Stampfer
MJ
,
Colditz
GA
,
Litin
LB
,
Willett
WC
.
Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals
.
Am J Epidemiol
1992
;
135
:
1114
1126; discussion 1127–1136
[PubMed]
17.
Hu
FB
,
Rimm
E
,
Smith-Warner
SA
, et al
.
Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire
.
Am J Clin Nutr
1999
;
69
:
243
249
[PubMed]
18.
McCullough
ML
,
Feskanich
D
,
Stampfer
MJ
, et al
.
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance
.
Am J Clin Nutr
2002
;
76
:
1261
1271
[PubMed]
19.
Rimm
EB
,
Stampfer
MJ
,
Colditz
GA
,
Chute
CG
,
Litin
LB
,
Willett
WC
.
Validity of self-reported waist and hip circumferences in men and women
.
Epidemiology
1990
;
1
:
466
473
[PubMed]
20.
Colditz
GA
,
Martin
P
,
Stampfer
MJ
, et al
.
Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women
.
Am J Epidemiol
1986
;
123
:
894
900
[PubMed]
21.
Ascherio
A
,
Rimm
EB
,
Giovannucci
EL
, et al
.
A prospective study of nutritional factors and hypertension among US men
.
Circulation
1992
;
86
:
1475
1484
[PubMed]
22.
Manson
JE
,
Rimm
EB
,
Stampfer
MJ
, et al
.
Physical activity and incidence of non-insulin-dependent diabetes mellitus in women
.
Lancet
1991
;
338
:
774
778
[PubMed]
23.
Hu
FB
,
Leitzmann
MF
,
Stampfer
MJ
,
Colditz
GA
,
Willett
WC
,
Rimm
EB
.
Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men
.
Arch Intern Med
2001
;
161
:
1542
1548
[PubMed]
24.
National Diabetes Data Group
.
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
.
Diabetes
1979
;
28
:
1039
1057
[PubMed]
25.
AmericanDiabetesAssociation
.
Report of the expert committee on the diagnosis and classification of diabetes mellitus
.
Diabetes Care
1997
;
20
:
1183
1197
[PubMed]
26.
Durrleman
S
,
Simon
R
.
Flexible regression models with cubic splines
.
Stat Med
1989
;
8
:
551
561
[PubMed]
27.
Lin
DY
,
Fleming
TR
,
De Gruttola
V
.
Estimating the proportion of treatment effect explained by a surrogate marker
.
Stat Med
1997
;
16
:
1515
1527
[PubMed]
28.
Kaushik
M
,
Mozaffarian
D
,
Spiegelman
D
,
Manson
JE
,
Willett
WC
,
Hu
FB
.
Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus
.
Am J Clin Nutr
2009
;
90
:
613
620
[PubMed]
29.
Heidemann
C
,
Hoffmann
K
,
Spranger
J
, et al.;
European Prospective Investigation into Cancer and Nutrition (EPIC)—Potsdam Study Cohort
.
A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)—Potsdam Study cohort
.
Diabetologia
2005
;
48
:
1126
1134
[PubMed]
30.
Imamura
F
,
Lichtenstein
AH
,
Dallal
GE
,
Meigs
JB
,
Jacques
PF
.
Generalizability of dietary patterns associated with incidence of type 2 diabetes mellitus
.
Am J Clin Nutr
2009
;
90
:
1075
1083
[PubMed]
31.
Liese
AD
,
Weis
KE
,
Schulz
M
,
Tooze
JA
.
Food intake patterns associated with incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study
.
Diabetes Care
2009
;
32
:
263
268
[PubMed]
32.
McNaughton
SA
,
Mishra
GD
,
Brunner
EJ
.
Dietary patterns, insulin resistance, and incidence of type 2 diabetes in the Whitehall II Study
.
Diabetes Care
2008
;
31
:
1343
1348
[PubMed]
33.
Schulze
MB
,
Hoffmann
K
,
Manson
JE
, et al
.
Dietary pattern, inflammation, and incidence of type 2 diabetes in women
.
Am J Clin Nutr
2005
;
82
:
675
684; quiz 714–715
[PubMed]
34.
Fung
TT
,
Schulze
M
,
Manson
JE
,
Willett
WC
,
Hu
FB
.
Dietary patterns, meat intake, and the risk of type 2 diabetes in women
.
Arch Intern Med
2004
;
164
:
2235
2240
[PubMed]
35.
de Koning
L
,
Chiuve
SE
,
Fung
TT
,
Willett
WC
,
Rimm
EB
,
Hu
FB
.
Diet-quality scores and the risk of type 2 diabetes in men
.
Diabetes Care
2011
;
34
:
1150
1156
[PubMed]
36.
Mozaffarian
D
,
Hao
T
,
Rimm
EB
,
Willett
WC
,
Hu
FB
.
Changes in diet and lifestyle and long-term weight gain in women and men
.
N Engl J Med
2011
;
364
:
2392
2404
[PubMed]
37.
Donath
MY
,
Shoelson
SE
.
Type 2 diabetes as an inflammatory disease
.
Nat Rev Immunol
2011
;
11
:
98
107
[PubMed]
38.
Bonnet
F
,
Disse
E
,
Laville
M
, et al.;
RISC Study Group
.
Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women
.
Diabetologia
2012
;
55
:
3228
3237
[PubMed]
39.
Pan
A
,
Sun
Q
,
Bernstein
AM
,
Manson
JE
,
Willett
WC
,
Hu
FB
.
Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: three cohorts of US men and women
.
JAMA Intern Med
2013
;
173
:
1328
1335
[PubMed]
40.
Joosten
MM
,
Chiuve
SE
,
Mukamal
KJ
,
Hu
FB
,
Hendriks
HFJ
,
Rimm
EB
.
Changes in alcohol consumption and subsequent risk of type 2 diabetes in men
.
Diabetes
2011
;
60
:
74
79
[PubMed]
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

Supplementary data